Analyst Expectations for Pacira BioSciences's Future
Portfolio Pulse from Benzinga Insights
Pacira BioSciences (NASDAQ:PCRX) has received 8 bullish analyst ratings in the last quarter, with an average price target of $57.88, implying an upside from the current price of $28.51. This average has decreased by 8.13% from the previous average price target of $63.00.
October 23, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Pacira BioSciences has received positive analyst ratings, suggesting potential upside.
The bullish analyst ratings indicate a positive outlook for Pacira BioSciences. The average price target suggests a significant upside from the current price, which could lead to an increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100